Cargando…

The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease

Detalles Bibliográficos
Autores principales:	Cebrian, Ana, Escobar, Carlos, Aranda, Unai, Palacios, Beatriz, Capel, Margarita, Sicras, Antoni, Sicras, Aram, Hormigo, Antonio, Manito, Nicolás, Botana, Manuel, Alcázar, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155243/ https://www.ncbi.nlm.nih.gov/pubmed/35664262 http://dx.doi.org/10.1093/ckj/sfac019

Ejemplares similares

Costs and healthcare utilisation of patients with chronic kidney disease in Spain
por: Escobar, Carlos, et al.
Publicado: (2021)

Risk of outcomes in a Spanish population with chronic kidney disease
por: Alcázar, Roberto, et al.
Publicado: (2022)

Costs and healthcare utilisation of patients with heart failure in Spain
por: Escobar, Carlos, et al.
Publicado: (2020)

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2013)

Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2021)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2007)

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
por: Neches García, Victoria, et al.
Publicado: (2022)

Sick Leave and Costs in Active Workers with Chronic Osteoarthritis Pain in Spain: Outcomes of the OPIOIDS Real World Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2022)

Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in Spain
por: Escobar-Cervantes, Carlos, et al.
Publicado: (2022)

Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease
por: Chen, Fang, et al.
Publicado: (2013)

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Physicians’ and patients’ opinions on the use of generic drugs
por: Sicras-Mainar, Antoni, et al.
Publicado: (2012)

Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
por: Irimia, Pablo, et al.
Publicado: (2022)

Treatment profiles and costs of patients with chronic pain in the population setting
por: Mainar, Antoni Sicras, et al.
Publicado: (2012)

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk
por: Corsetti, James P., et al.
Publicado: (2019)

Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain
por: Rejas-Gutierrez, Javier, et al.
Publicado: (2021)

Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society
por: Chrysohoou, Christina, et al.
Publicado: (2020)

Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study
por: Soler-Cataluña, Juan José, et al.
Publicado: (2023)

Non-obstructive cardiovascular disease: a new challenge for invasive cardiology?
por: Wittekoek, M. E., et al.
Publicado: (2017)

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease
por: Weerarathna, Thilak, et al.
Publicado: (2018)

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study
por: Cordero, Alberto, et al.
Publicado: (2023)

Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices
por: Özel, Erdem, et al.
Publicado: (2019)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
por: Sicras Mainar, Antoni, et al.
Publicado: (2019)

Severe Atopic Dermatitis In Spain: A Real-Life Observational Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2019)

Association of Metabolic Syndrome and Albuminuria with Cardiovascular Risk in Occupational Drivers
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Chest Pain, Atherosclerotic Cardiovascular Disease Risk, and Cardiology Referral in Primary Care
por: Buch, Vishaal, et al.
Publicado: (2018)

The TIMI Study Group’s Contributions to the Advancement of Cardiology -With Focus on Atherosclerotic Cardiovascular Disease-
por: Toda Kato, Eri, et al.
Publicado: (2021)

Developing a curriculum to improve cardiology fellows’ training in pregnancy and cardiovascular disease
por: Maxner, Benjamin, et al.
Publicado: (2022)

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease
por: Fonarow, Gregg C., et al.
Publicado: (2021)

Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
por: Lees, Jennifer S, et al.
Publicado: (2019)

Cardiovascular risk assessment: The foundation of preventive cardiology
por: Wong, Nathan D.
Publicado: (2020)

Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8ns1fgn6akb6h81sa73s48dcl